These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10580977)

  • 1. Assessing the effect of hormone replacement therapy on the performance of screening mammography.
    Thomas CM
    Radiology; 1999 Dec; 213(3):926-7. PubMed ID: 10580977
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of hormone replacement therapy on cancer detection by mammography.
    Johnson A; Shekhdar J
    Lancet; 1997 May; 349(9065):1624-5. PubMed ID: 9174579
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
    Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
    Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Vaidya JS
    J Natl Cancer Inst; 2008 Apr; 100(8):598-9; author reply 599. PubMed ID: 18398100
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of hormone replacement therapy on cancer detection by mammography.
    Cohen ME
    Lancet; 1997 May; 349(9065):1624. PubMed ID: 9174578
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity.
    Harvey JA; Pinkerton JV; Herman CR
    J Natl Cancer Inst; 1997 Nov; 89(21):1623-5. PubMed ID: 9362162
    [No Abstract]   [Full Text] [Related]  

  • 7. [Opinions, beliefs and awareness about the value of mammography screening].
    Steurer J
    Praxis (Bern 1994); 2010 Oct; 99(20):1177-8. PubMed ID: 20954423
    [No Abstract]   [Full Text] [Related]  

  • 8. [Commentary from the viewpoint of an advocate. "Breast cancer mortality in organized mammography screening in Denmark--a comparative Study"].
    Thürlimann B
    Praxis (Bern 1994); 2010 Oct; 99(20):1217-8. PubMed ID: 20931497
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic factors of breast neoplasms detected on screening by mammography and physical examination.
    Feig SA; Schwartz GF; Nerlinger R; Edeiken J
    Radiology; 1979 Dec; 133(3 Pt 1):577-82. PubMed ID: 504635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Critical comment. "Breast cancer mortality in organized mammography screening in Denmark--a comparative Study"].
    Bucher HC
    Praxis (Bern 1994); 2010 Oct; 99(20):1219-20. PubMed ID: 20931498
    [No Abstract]   [Full Text] [Related]  

  • 11. Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices.
    LeBlanc ES; Viscoli CM; Henrich JB
    J Womens Health Gend Based Med; 1999; 8(6):815-23. PubMed ID: 10495262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method.
    Roubidoux MA; Wilson TE; Orange RJ; Fitzgerald JT; Helvie MA; Packer SA
    Radiology; 1998 Sep; 208(3):725-8. PubMed ID: 9722852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Kerlikowske K; Miglioretti DL; Buist DS; Walker R; Carney PA;
    J Natl Cancer Inst; 2007 Sep; 99(17):1335-9. PubMed ID: 17698950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancer.
    Johnson A; Shekhdar J
    Breast; 2005 Feb; 14(1):79. PubMed ID: 15695088
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined clinical and mammographic mass screening in breast cancer].
    Lányi M; László G; Farkas M
    Fortschr Geb Rontgenstr Nuklearmed; 1970 Jan; 11(1):18-26. PubMed ID: 4324683
    [No Abstract]   [Full Text] [Related]  

  • 16. Is mammographic screening for breast cancer losing ground?
    Arya V
    Natl Med J India; 2000; 13(4):203-4. PubMed ID: 11002689
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of mammography for detecting early breast cancer in women under 50.
    Yokoe T; Iino Y; Maemura M; Takei H; Horiguchi J; Matsumoto H; Morishita Y; Koibuchi Y
    Anticancer Res; 1998; 18(6B):4709-11. PubMed ID: 9891545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is estrogen therapy of significance for the incidence of breast cancer?].
    Bakken K
    Tidsskr Nor Laegeforen; 2004 Nov; 124(21):2801; author reply 2801. PubMed ID: 15534689
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ductal carcinoma in situ of the breast].
    Barth A; Köchli OR; Brenner RJ; Giuliano E; Castiglione M
    Schweiz Med Wochenschr; 1995 Jan; 125(4):103-12. PubMed ID: 7878398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer in Missouri: staging, survival, and mammography screening patterns.
    Brownson RC; Chang JC; Davis JR; Wilkerson JC; Thompson JJ
    Mo Med; 1990 Oct; 87(10):753-6. PubMed ID: 2259329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.